Acute interventions for ischemic stroke: Present status and future directions

Journal of Endovascular Therapy

Volumn 7, Issue 5, 2000, Pages 423-428

  Qureshi, A I ^a   Ringer, A J ^a   Suri, M F K ^a   Guterman, L R ^a   Hopkins, L N ^a  

^a Department of Neurosurgery ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; HEPARIN; PROLYSE; RETEPLASE; SARUPLASE; UROKINASE;

ARTICLE; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG EFFICACY; DRUG HALF LIFE; DRUG MEGADOSE; DRUG STRUCTURE; EMERGENCY TREATMENT; FIBRINOLYTIC THERAPY; HUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; THROMBECTOMY;

EID: 0033771431     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1177/152660280000700512     Document Type: Article

References (22)

1. Tissue plasminogen activator for acute ischemic stroke
2. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke
3. Thrombolytic therapy with streptokinase in acute ischemic stroke
4. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group
5. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke
6. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
7. Pro-urokinase: A study of its stability in plasma and of a mechanism for its selective fibrinolytic effect
8. Thrombolysis in acute myocardial infarction
9. Molecular biology of plasminogen activators: What are the clinical implications of drug design?
10. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I. A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge
11. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery
12. PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism
13. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism
14. Combined intravenous and intra-arterial r-tPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial
15. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke
16. Multivariable analysis of predictive factors related to outcome at 6 months after intra-arterial thrombolysis for acute ischemic stroke
17. Intracranial intra-arterial thrombolysis facilitated by microcatheter navigation through an occluded cervical internal carotid artery
18. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke
19. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials
20. Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries
21. Catheter-based local thrombolysis with urokinase: Comparative efficacy of intraluminal clot lysis with conventional urokinase infusion techniques in an in vivo porcine thrombus model
22. Enhanced laser thrombolysis with photomechanical drug delivery: An in vitro study